Real-time enrollment status for this chronic hepatitis b infection clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 1:45 AM UTC
| NCT Number | NCT07342881 |
| Recruiting Status | Recruiting |
| Condition | Chronic Hepatitis B Infection |
| Phase | PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Aligos Therapeutics |
| Last Updated on CT.gov | February 27, 2026 (Feb 27, 2026) |
As of July 21, 2026: Clinical trial NCT07342881 is currently recruiting participants. This phase1 study for chronic hepatitis b infection is actively seeking new participants at 2 locations across the United States. The study is sponsored by Aligos Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07342881 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07342881 was last updated Feb 27, 2026 (February 27, 2026). HelloStudys verifies this status automatically.